Hyogo Prefectural Kakogawa Hospital

Kakogawa, Japan

Hyogo Prefectural Kakogawa Hospital

Kakogawa, Japan
SEARCH FILTERS
Time filter
Source Type

Kawano M.,Kochi Medical School | Sawada K.,Kochi Medical School | Sawada K.,Aki General Hospital | Shimodera S.,Kochi Medical School | And 5 more authors.
PLoS ONE | Year: 2015

Background Reduced hippocampal volume in schizophrenia is a well-replicated finding. New imaging techniques allow delineation of hippocampal subfield volumes. Studies including predominantly chronic patients demonstrate differences between subfields in sensitivity to illness, and in associations with clinical features. We carried out a cross-sectional and longitudinal study of first episode, sub-chronic, and chronic patients, using an imaging strategy that allows for the assessment of multiple hippocampal subfields. Methods Hippocampal subfield volumes were measured in 34 patients with schizophrenia (19 first episode, 6 sub-chronic, 9 chronic) and 15 healthy comparison participants. A subset of 10 first episode and 12 healthy participants were rescanned after six months. Results Total left hippocampal volume was smaller in sub-chronic (p = 0.04, effect size 1.12) and chronic ( p = 0.009, effect size 1.42) patients compared with healthy volunteers. The CA2-3 subfield volume of chronic patients was significantly decreased (p = 0.009, effect size 1.42) compared to healthy volunteers. The CA4-DG volume was significantly reduced in all three patient groups compared to healthy group (all p < 0.005). The two affected subfield volumes were inversely correlated with severity of negative symptoms (p < 0.05). There was a small, but statistically significant decline in left CA4-DG volume over the first six months of illness (p = 0.01). Conclusions Imaging strategies defining the subfields of the hippocampus may be informative in linking symptoms and structural abnormalities, and in understanding more about progression during the early phases of illness in schizophrenia. © 2015 Kawano et al.


Matsuo H.,Hiroshima University | Uemura M.,Hiroshima University | Yorozuya M.,Hiroshima University | Adachi A.,Hyogo Prefectural Kakogawa Hospital | Morita E.,The University of Shimane
Contact Dermatitis | Year: 2010

Background: Wheat protein and its derivatives can cause protein contact dermatitis (PCD), which mainly occurs in bakers. Few studies have attempted to identify the allergens responsible for wheat PCD. Objectives: The aim of this study was to identify allergenic wheat proteins in patients with wheat PCD. Methods: Water-soluble and water-insoluble wheat flour proteins were separated by 1- or 2-dimensional gel electrophoresis. IgE-binding proteins were detected by immunoblotting with sera from 3 wheat PCD patients and identified by N-terminal amino acid sequence analysis. The IgE-binding proteins were recombinantly expressed in Escherichia coli and tested against patients' sera. Results: IgE antibodies from the patients' sera reacted with water-soluble proteins rather than water-insoluble proteins, and the 2-dimensional electrophoresis and immunoblotting produced individual IgE-binding patterns. Analysis of the N-terminal amino acid sequence of the IgE-binding proteins from the 2-dimensional gel led to the identification of three glycoproteins, wheat 27-kDa allergen, peroxidase, and purple acid phosphatase. No specific IgE antibodies to their non-glycosylated recombinant proteins were observed. Conclusions: We identified wheat 27-kDa allergen, peroxidase and purple acid phosphatase as candidate allergens for wheat PCD. Our results suggest that glycan moieties in these proteins are involved in IgE binding. © 2010 John Wiley & Sons A/S.


PubMed | University of British Columbia, Hyogo Prefectural Kakogawa Hospital, Fukushima Medical University, Aki General Hospital and Kochi Medical School
Type: Journal Article | Journal: PloS one | Year: 2015

Reduced hippocampal volume in schizophrenia is a well-replicated finding. New imaging techniques allow delineation of hippocampal subfield volumes. Studies including predominantly chronic patients demonstrate differences between subfields in sensitivity to illness, and in associations with clinical features. We carried out a cross-sectional and longitudinal study of first episode, sub-chronic, and chronic patients, using an imaging strategy that allows for the assessment of multiple hippocampal subfields.Hippocampal subfield volumes were measured in 34 patients with schizophrenia (19 first episode, 6 sub-chronic, 9 chronic) and 15 healthy comparison participants. A subset of 10 first episode and 12 healthy participants were rescanned after six months.Total left hippocampal volume was smaller in sub-chronic (p = 0.04, effect size 1.12) and chronic (p = 0.009, effect size 1.42) patients compared with healthy volunteers. The CA2-3 subfield volume of chronic patients was significantly decreased (p = 0.009, effect size 1.42) compared to healthy volunteers. The CA4-DG volume was significantly reduced in all three patient groups compared to healthy group (all p < 0.005). The two affected subfield volumes were inversely correlated with severity of negative symptoms (p < 0.05). There was a small, but statistically significant decline in left CA4-DG volume over the first six months of illness (p = 0.01).Imaging strategies defining the subfields of the hippocampus may be informative in linking symptoms and structural abnormalities, and in understanding more about progression during the early phases of illness in schizophrenia.


Maki T.,Kobe University | Yamamoto D.,Kobe University | Nakanishi S.,Kobe University | Iida K.,Hyogo Prefectural Kakogawa Hospital | And 5 more authors.
Nutrition Research | Year: 2012

Atrogin-1 and MuRF1, muscle-specific ubiquitin ligases, and autophagy play a role in protein degradation in muscles. We hypothesized that branched-chain amino acids (BCAAs) may decrease atrogin-1, MuRF1, and autophagy, and may have a protective effect on disuse muscle atrophy. To test this hypothesis, we selected hindlimb suspension (HS)-induced muscle atrophy as a model of disuse muscle atrophy because it is an established model to investigate the effects of decreased muscle activity. Sprague-Dawley male rats were assigned to 4 groups: control, HS (14 days), oral BCAA administration (600 mg/[kg day], 22.9% l-isoleucine, 45.8% l-leucine, and 27.6% l-valine), and HS and BCAA administration. After 14 days of the treatment, muscle weights and protein concentrations, cross-sectional area (CSA) of the muscle fibers, atrogin-1 and MuRF1 proteins, and microtubule-associated protein 1 light chain 3 II/I (ratio of LC3 II/I) were measured. Hindlimb suspension significantly reduced soleus muscle weight and CSA of the muscle fibers. Branched-chain amino acid administration partly but significantly reversed the HS-induced decrease in CSA. Hindlimb suspension increased atrogin-1 and MuRF1 proteins, which play a pivotal role in various muscle atrophies. Branched-chain amino acid attenuated the increase in atrogin-1 and MuRF1 in soleus muscles. Hindlimb suspension significantly increased the ratio of LC3 II/I, an indicator of autophagy, whereas BCAA did not attenuate the increase in the ratio of LC3 II/I. These results indicate the possibility that BCAA inhibits HS-induced muscle atrophy, at least in part, via the inhibition of the ubiquitin-proteasome pathway. Oral BCAA administration appears to have the potential to prevent disuse muscle atrophy. © 2012 Elsevier Inc.


Handayaningsih A.-E.,Kobe University | Iguchi G.,Kobe University | Fukuoka H.,Kobe University | Nishizawa H.,Kobe University | And 8 more authors.
Endocrinology | Year: 2011

IGF-I induces skeletal muscle hypertrophy by stimulating protein synthesis and suppressing the protein degradation pathway; the downstream signaling pathways Akt-mammalian target of rapamycin (mTOR)-p70-kDA-S6-kinase (p70S6K), and Forkhead box O1 (FoxO1) play essential roles in this regulation. Reactive oxygen species (ROS) modulate the signaling of various growth factors via redox regulation. However, the role of ROS in IGF-I signaling is not fully understood. In this study, we investigated whether ROS regulate the signaling and biological action of IGF-I in C2C12 myocytes.We found that IGF-I induces ROS in C2C12 myocytes. While treatment with H2O2 significantly enhanced IGF-I-induced phosphorylation of the IGF-I receptor (IGF-IR), IGF-IR phosphorylation was markedly attenuated when cells were treated with antioxidants. The downstream signaling pathway, Aktm-TOR-p70S6K was subsequently down-regulated.Furthermore,the phosphorylation of FoxO1 by IGF-I decreased concomitantly with the restoration of the expression of its target genes, Atrogin-1 and muscle RING finger 1, which are related to muscle atrophy. Nox4 knockdown, which is reportedly to produce ROS in insulin signaling, attenuated IGF-I-induced IGF-IR phosphorylation, indicating that Nox4 is involved in the regulation of IGF-I signaling. Importantly, antioxidant treatments inhibited IGF-I-induced myocyte hypertrophy, demonstrating that ROS are necessary for IGF-I-induced myocyte hypertrophyin vitro. These results indicate that ROS play an essential role in the signaling and biological action of IGF-I in C2C12 myocytes. Copyright © 2011 by The Endocrine Society.


Yamamoto D.,Kobe University | Maki T.,Kobe University | Herningtyas E.H.,Kobe University | Ikeshita N.,Kobe University | And 9 more authors.
Muscle and Nerve | Year: 2010

We investigated the utility of branched-chain amino acids (BCAA) in dexamethasone-induced muscle atrophy. Dexamethasone (600 μg/kg, intraperitoneally) and/or BCAA (600 mg/kg, orally) were administered for 5 days in rats, and the effect of BCAA on dexamethasone-induced muscle atrophy was evaluated. Dexamethasone decreased total protein concentration of rat soleus muscles. Concomitant administration of BCAA reversed the decrease. Dexamethasone decreased mean cross-sectional area of soleus muscle fibers, which was reversed by BCAA. Dexamethasone increased atrogin-1 expression, which has been reported to play a pivotal role in muscle atrophy. The increased expression of atrogin-1 mRNA was significantly attenuated by BCAA. Furthermore, dexamethasone-induced conversion from microtubule-associated protein 1 light chain 3 (LC3)-I to LC3-II, which is an indicator of autophagy, was blocked by BCAA. These findings suggest that BCAA decreased protein breakdown to prevent muscle atrophy. BCAA administration appears to be useful for prevention of steroid myopathy. © 2010 Wiley Periodicals, Inc.


Sugiyama Y.,Kobe University | Ikeshita N.,Kobe University | Shibahara H.,Kobe University | Yamamoto D.,Kobe University | And 8 more authors.
Molecular and Cellular Endocrinology | Year: 2013

PROP1 cofactors have not yet been identified. In the present study, we aimed to identify the PROP1-interacting proteins from the human brain cDNA library. Using a yeast two-hybrid assay, we cloned nine candidate proteins that may bind to PROP1. Of those nine candidates, amino-terminal enhancer of split (AES) was the most abundant, and we analyzed the AES function. AES dose-dependently decreased the PROP1-induced Pit-1 reporter gene expression. An immunoprecipitation assay revealed the relationship between AES and PROP1. In a mammalian two-hybrid assay, a leucine zipper-like motif of the AES Q domain was identified as a region that interacted with TAD. These results indicated that AES was a corepressor of PROP1. © 2013 Elsevier Ireland Ltd.


Adachi A.,Hyogo Prefectural Kakogawa Hospital
Arerugī = [Allergy] | Year: 2013

A large-scale study of causative allergen components of shrimp allergies has never been conducted in Japan. A total of 31 patients with shrimp allergy who were referred to the Kakogawa Prefectural Medical Center from January 2004 to August 2011 were enrolled in the study. Shrimp allergy was diagnosed according to the clinical symptoms, and positive prick testing using black tiger shrimp. Serum-specific IgE to two preparations of shrimp allergens (shrimp: shrimp extracts used before June 2012; and new shrimp: shrimp extracts used after July 2012 for ImmunoCAP®) and tropomyosin was determined with ImmunoCAP® (CAP-FEIA, Phadia) . Western blot analysis was performed using soluble and insoluble fractions from black tiger shrimp to define the causative shrimp allergens. In 31 cases of shrimp allergy, detection rate (more than class 1) of allergen-specific IgE to conventional shrimp was 58.1%, to new shrimp was 66.7%, and to tropomyosin was 29.0%. Positive rate (more than class 2) of allergen-specific IgE to conventional shrimp was 54.8%, to new shrimp was 55.0%, and to tropomyosin was 19.4%. In the 5 cases of FDEIA, detection rate of allergen-specific IgE to conventional shrimp was 20%, to new shrimp was 40%, and to tropomyosin was 0%. In the 19 cases of immediate-type allergy, detection rate of allergen-specific IgE to conventional shrimp was 68.4%, to new shrimp was 66.7%, and to tropomyosin was 36.8%. In the 7 cases of OAS, detection rate of allergen-specific IgE to shrimp was 57.1%, to new shrimp was 85.7%, and to tropomyosin was 28.5%. Western blot analysis of the 31 cases showed that several cases showed a band with a molecular weight of 35-38 kDa, which corresponds to tropomyosin. However, a 70-kDa band was detected in 30 of 31 cases. The 70-kDa protein may be a new major allergen component of shrimp allergy.


A 47 years-old woman suffering from baker's asthma for several years developed anaphylaxis when she was walking hard after taking wheat. On the provocation test, neither wheat alone nor exercise alone induced any symptoms. The combination of exercise, wheat and aspirin induced urticaria and marked elevation of blood gliadin levels. According to the high titer of omega-5 gliadin specific IgE in her serum and the result of challenge test, we diagnosed wheat-dependent exercise-induced anaphylaxis (WDEIA). By means of western blotting of soluble and insoluble wheat proteins, we detected several bands which were supposed to be beta-, gamma- and omega-5 gliadin by their relative molecular mass. Wheat gliadins might be causative allergen of both baker's asthma and WDEIA in our case.


PubMed | Hyogo Prefectural Kakogawa Hospital
Type: Journal Article | Journal: Arerugi = [Allergy] | Year: 2013

A large-scale study of causative allergen components of shrimp allergies has never been conducted in Japan.A total of 31 patients with shrimp allergy who were referred to the Kakogawa Prefectural Medical Center from January 2004 to August 2011 were enrolled in the study. Shrimp allergy was diagnosed according to the clinical symptoms, and positive prick testing using black tiger shrimp.Serum-specific IgE to two preparations of shrimp allergens (shrimp: shrimp extracts used before June 2012; and new shrimp: shrimp extracts used after July 2012 for ImmunoCAP) and tropomyosin was determined with ImmunoCAP (CAP-FEIA, Phadia) . Western blot analysis was performed using soluble and insoluble fractions from black tiger shrimp to define the causative shrimp allergens.In 31 cases of shrimp allergy, detection rate (more than class 1) of allergen-specific IgE to conventional shrimp was 58.1%, to new shrimp was 66.7%, and to tropomyosin was 29.0%. Positive rate (more than class 2) of allergen-specific IgE to conventional shrimp was 54.8%, to new shrimp was 55.0%, and to tropomyosin was 19.4%. In the 5 cases of FDEIA, detection rate of allergen-specific IgE to conventional shrimp was 20%, to new shrimp was 40%, and to tropomyosin was 0%. In the 19 cases of immediate-type allergy, detection rate of allergen-specific IgE to conventional shrimp was 68.4%, to new shrimp was 66.7%, and to tropomyosin was 36.8%. In the 7 cases of OAS, detection rate of allergen-specific IgE to shrimp was 57.1%, to new shrimp was 85.7%, and to tropomyosin was 28.5%. Western blot analysis of the 31 cases showed that several cases showed a band with a molecular weight of 35-38 kDa, which corresponds to tropomyosin. However, a 70-kDa band was detected in 30 of 31 cases.The 70-kDa protein may be a new major allergen component of shrimp allergy.

Loading Hyogo Prefectural Kakogawa Hospital collaborators
Loading Hyogo Prefectural Kakogawa Hospital collaborators